




Searching News Database: histrelin
HSMN NewsFeed - 26 Sep 2008
Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
HSMN NewsFeed - 3 Mar 2008
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
HSMN NewsFeed - 17 Aug 2007
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
HSMN NewsFeed - 29 Jun 2007
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
HSMN NewsFeed - 25 Jun 2007
Indevus Announces Launch of SUPPRELIN(R) LA for Central Precocious Puberty
Indevus Announces Launch of SUPPRELIN(R) LA for Central Precocious Puberty
HSMN NewsFeed - 31 May 2007
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
HSMN NewsFeed - 19 Apr 2007
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
Additional items found! 9

Members Archive contains
9 additional stories matching:
histrelin
(Password required)
histrelin
(Password required)